Y Combinator placing a bet on a new generation of biotech start-ups

Y CombinatorY Combinator, the well-known Silicon Valley accelerator, is betting that biotech start-ups that use the latest computer science technologies such as machine learning will grow much more quickly than their counterparts and, as a result, should be funded more like tech start-ups. Read more about the team’s thinking here.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.